z-logo
open-access-imgOpen Access
Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19
Author(s) -
Jan Wysocki,
Enrique Lores,
Minghao Ye,
María José Soler,
Daniel Batlle
Publication year - 2020
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2020050667
Subject(s) - telmisartan , tmprss2 , angiotensin converting enzyme 2 , angiotensin ii receptor type 1 , kidney , lung , renin–angiotensin system , receptor , medicine , endocrinology , dipeptidyl peptidase 4 , angiotensin ii , pharmacology , diabetes mellitus , covid-19 , type 2 diabetes , disease , blood pressure , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here